Skip to main content
. 2022 Sep 20;14(10):1988. doi: 10.3390/pharmaceutics14101988

Figure 3.

Figure 3

Photoacoustic/magnetic resonance dual-mode imaging. (A) Photoacoustic imaging at different concentrations of Nec-1/PDA@Pt-Fe3O4 in vitro, Photoacoustic imaging of mice kidney before (B) and after (C) adding 1mg/mL Nec-1/PDA@Pt-Fe3O4 in vivo. (D) T2-weighted magnetic resonance imaging in vitro at different concentrations of Nec-1/PDA@Pt-Fe3O4. Magnetic resonance imaging of mice kidneys before (E) and after (F) adding Nec-1/PDA@Pt-Fe3O4 in vivo.